Asosiy kontentga oʻtish
Maqola

Evolution of risk management in diabetes mellitus: from standardized restrictions to personalized technological solutions

S. J. QosimovaDepartment of Endocrinology, SEI Institute of Postgraduate Education in Healthcare of the Republic of Tajikistan
2026
ABI

Annotatsiya

Diabetes mellitus (DM) represents one of the most significant medico-social problems, characterized by a steady increase in morbidity and a high burden of complications. Historically, risk management was based on strict dietary restrictions and unified insulin therapy protocols, which often failed to ensure adequate compensation of the disease and a satisfactory quality of life for patients. In the context of the development of digital technologies and evidence-based medicine, the treatment paradigm is undergoing a fundamental change. Systematic literature reviews published between 2009 and 2024 in PubMed, Scopus, Web of Science, and eLibrary, along with the results of meta-analyses, randomized controlled trials, and cohort studies, were analyzed to identify the key stages of the transition from unified approaches to the diagnosis and treatment of diabetes mellitus toward personalized technological solutions in diabetes management. This article established that the transition from the concept of “avoiding acute conditions” to the strategy of “preventing chronic complications” became possible due to the introduction of HbA1c (glycated hemoglobin) as a standard for monitoring the effectiveness of therapy. The technological revolution (development of insulin analogs, continuous glucose monitoring systems, insulin pumps) shifted the focus to glycemic variability and Time in Range (TIR) during the day. Treatment personalization now includes digital tools, pharmacogenetics, and psychosocial support.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar